# Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer

> **NCT00005993** · PHASE1 · TERMINATED · sponsor: **Masonic Cancer Center, University of Minnesota**

## Conditions studied

- Breast Cancer
- Lymphoma

## Interventions

- **DRUG:** aldesleukin
- **DRUG:** filgrastim
- **DRUG:** recombinant human stem cell factor
- **PROCEDURE:** peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00005993
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1999-05
- **Primary completion:** 2005-07
- **Final completion:** 2005-07
- **Target enrollment:** — (—)
- **Last updated:** 2017-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005993, "Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00005993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*